The aim of this study is to provide a comprehensive and
up-to-date synthesis of the clinical understanding of Pickwickian Syndrome,
with a focus on its diagnosis, management, and associated complications.
Pickwickian Syndrome, or Obesity Hypoventilation Syndrome (OHS), is a serious
obesity-related respiratory disorder defined by chronic daytime hypercapnia
(PaCO₂ > 45 mmHg), obesity (BMI ≥ 30 kg/m²), and exclusion of other
hypoventilation causes. It arises from a complex interplay of impaired
ventilatory drive, leptin resistance, and mechanical respiratory restriction,
often coexisting with obstructive sleep apnea (OSA) in nearly 90% of cases. OHS
leads to chronic hypoxemia, pulmonary hypertension, and cor pulmonale if
untreated. Diagnosis relies on arterial blood gas analysis, polysomnography,
and exclusion of alternative etiologies. A key diagnostic feature is chronic
hypercapnia (PaCO₂ >45 mmHg), often accompanied by compensated metabolic
alkalosis due to renal bicarbonate retention.
There may also be hypoxemia (PaO₂ <70 mmHg), particularly in more
severe cases. Management requires a multidisciplinary approach emphasising
weight reduction, lifestyle modification, and positive airway pressure (PAP)
therapy—CPAP for OHS with OSA and BiPAP for persistent hypercapnia. Bariatric
surgery offers substantial improvement in severe cases. Pharmacologic agents
like acetazolamide and medroxyprogesterone serve limited roles. Early
recognition and adherence to therapy markedly improve outcomes, reducing
mortality from 30% to under 10%. Despite advancements, OHS remains
underdiagnosed and undertreated, highlighting the need for greater clinical
awareness, digital monitoring integration, and personalised management
strategies.
Author(s) Details
Harsahaj Singh
Wilkhoo
Faculty of Medicine, Tbilisi State Medical University, Tbilisi, Georgia.
Afra Wasama Islam
Faculty of Medicine, Tbilisi State Medical University, Tbilisi, Georgia.
Please see the book here :- https://doi.org/10.9734/bpi/msup/v2/6708
No comments:
Post a Comment